These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3749812)

  • 1. Serum amyloid P-component levels in patients with malignancy.
    Levo Y; Wollner S; Treves AJ
    Scand J Immunol; 1986 Aug; 24(2):147-51. PubMed ID: 3749812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases.
    Weinstein PS; Skinner M; Sipe JD; Lokich JJ; Zamcheck N; Cohen AS
    Scand J Immunol; 1984 Mar; 19(3):193-8. PubMed ID: 6200925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.
    Pepys MB; Dash AC; Markham RE; Thomas HC; Williams BD; Petrie A
    Clin Exp Immunol; 1978 Apr; 32(1):119-24. PubMed ID: 668189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
    de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
    Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid P-component as a marker of liver disease.
    Levo Y; Shalit M; Tur-Kaspa R
    Am J Gastroenterol; 1982 Jun; 77(6):427-30. PubMed ID: 7091128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of platelet activation by the amyloid P-component of serum.
    Fiedel BA; Ku CS; Izzi JM; Gewurz H
    J Immunol; 1983 Sep; 131(3):1416-9. PubMed ID: 6886420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced interleukin 1 (IL-1) production mediated by mouse serum amyloid P component.
    Sarlo KT; Mortensen RF
    Cell Immunol; 1985 Jul; 93(2):398-405. PubMed ID: 3873997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
    Baltz ML; Dyck RF; Pepys MB
    Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid P-component as a marker of liver involvement in measles infection.
    Levo Y; Wollner S; Shalit M
    Am J Gastroenterol; 1985 May; 80(5):391-2. PubMed ID: 3993639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
    Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
    Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
    Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
    Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogeny and expression analysis of C-reactive protein (CRP) and serum amyloid-P (SAP) like genes reveal two distinct groups in fish.
    Lee PT; Bird S; Zou J; Martin SAM
    Fish Shellfish Immunol; 2017 Jun; 65():42-51. PubMed ID: 28336487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis.
    Bharadwaj D; Mold C; Markham E; Du Clos TW
    J Immunol; 2001 Jun; 166(11):6735-41. PubMed ID: 11359830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
    Mortensen RF; Beisel K; Zeleznik NJ; Le PT
    J Immunol; 1983 Feb; 130(2):885-9. PubMed ID: 6600258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serum amyloid P component on human lymphocytes.
    Levo Y; Wollner S
    Int Arch Allergy Appl Immunol; 1985; 77(3):322-5. PubMed ID: 3874171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carcinoembryonic antigen and acute phase reactant proteins in the pre-operative detection of fixation of colorectal tumours.
    Durdey P; Williams NS; Brown DA
    Br J Surg; 1984 Nov; 71(11):881-4. PubMed ID: 6498459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid P-component and C-reactive protein in serum of healthy Icelanders and members of an Icelandic family with macroglobulinaemia.
    Jensson O; Björnsson OG; Arnason A; Birgisdóttir B; Pepys MB
    Acta Med Scand; 1982; 211(5):341-5. PubMed ID: 6810656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs.
    Mold C; Gresham HD; Du Clos TW
    J Immunol; 2001 Jan; 166(2):1200-5. PubMed ID: 11145702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.